Pulmatrix Reports 2017 Financial Results; Provides 2018 Outlook on Pulmonary Disease Pipeline

March 13, 2018

Responsive image

LEXINGTON, Mass., March 13, 2018 /PRNewswire/ — Pulmatrix, Inc. (NASDAQ: PULM) today announces 2017 financial results, reviews the Company’s recent progress, and provides an outlook for its pulmonary disease development pipeline.
“The Company continues to advance its iSPERSE-based…

Category: Precious Metals